Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTPγS binding in morphine-dependent mice

Drug and Alcohol Dependence

Volumn 50, Issue 3, 1998, Pages 241-249

  Romero, Julián ^a   Fernández Ruiz, J Javier ^a   Vela, Gema ^a   Ruiz Gayo, Mariano ^a   Fuentes, J Angel ^a   Ramos, J Antonio ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

9 tetrahydrocannabinol; Autoradiography; Cannabinoid agonist stimulated 35S GTP S binding; Cannabinoid receptor binding; Cannabinoids; Morphine dependence; Opiates

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MORPHINE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CENTRAL GRAY MATTER; CONTROLLED STUDY; GLOBUS PALLIDUS; MALE; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; SUBSTANTIA NIGRA;

ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN MAPPING; CANNABINOIDS; DRUG INTERACTIONS; DRUG TOLERANCE; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; MORPHOLINES; NAPHTHALENES; RADIOLIGAND ASSAY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SULFUR RADIOISOTOPES;

ANIMALIA;

EID: 0344878843     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00036-2     Document Type: Article

References (41)

1. 9-tetrahydrocannabinol. Eur. J. Pharmacol. 36:1976;259-264.
2. Bidaut-Russell M., Howlett A. Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum. Adv. Biosci. 75:1989;165-168.
3. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology. 102:1990;156-162.
4. Devane W.A., Spain J.W., Coscia C.J., Howlett A.C. An assessment of the role of opioid receptors in the response to cannabinomimetic drugs. J. Neurochem. 46:1986;1929-1935.
5. De Vries T.J., Van Vliet B.J., Hogenboom F., Wardeh G., Van der Laan J.W., Mulder A.H., Schoffelmeer A.N.M. Effect of chronic prenatal treatment on μ-opioid receptor-regulated adenylate cyclase activity and neurotransmitter release in rat brain slices. Eur. J. Pharmacol. 208:1991;97-104.
6. Dewey W.L. Cannabinoid pharmacology. Pharmacol. Rev. 38:1986;151-178.
7. Gardner E.L., Lowinson J.H. Marijuana's interaction with brain reward system: Update 1991. Pharmacol. Biochem. Behav. 40:1991;571-580.
8. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa D.R., Rice K.C. Cannabinoid receptor localization in brain. PNAS USA. 87:1990;1932-1936.
9. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
10. Hine B., Friedman E., Torrelio M., Gershon S. Morphine dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol. Science. 187:1975;443-445.
11. 9-tetrahydrocannabinol-tolerant rats. Psychopharmacology. 55:1977;243-249.
12. Kaymakçalan, S., 1979. Pharmacological similarities and interactions between cannabinoids and opioids. In: Nahas, G.G., Paton, W.D.M., (Eds.), Marihuana: Biological Effects, Pergamon, New York, pp. 591-604.
13. Kenakin, T., 1993. Efficacy. In: Kenakin, T., (Ed.), Pharmacologic Analysis of Drug-Receptor Interaction, Raven Press, New York. pp. 249-277.
14. 9-tetrahydrocannabinol on the levels of opioid peptides, gonadotrophin-releasing hormone and substance P in the adult male rat brain. Brain Res. 525:1990;78-83.
15. Lehmann, A., 1974. Atlas stèrèotaxique du Cerveau de la Souris. Centre National de la Recherche Scientifique, Paris.
16. Lichtman A.H., Cook S.A., Martin B.R. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J. Pharmacol. Exp. Ther. 276:1996;585-593.
17. Mailleux P., Vanderhaeghen J.-J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization hystochemistry. Neuroscience. 48:1992;655-668.
18. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
19. Martin B.R. Structural requirements for cannabinoid-induced antinociceptive activity in mice. Life Sci. 36:1985;1523-1530.
20. Nestler E.J., Erdos J.J., Terwilliger R., Duman R.S., Tallman J.F. Regulation of G-proteins by chronic morphine treatment in the rat locus coeruleus. Brain Res. 476:1989;230-239.
21. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12:1992;2439-2450.
22. 9-tetrahydrocannabinol and morphine in the spinal cord. J. Pharmacol. Exp. Ther. 279:1996;608-616.
23. 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors. Eur. J. Pharmacol. 318:1996;11-16.
24. 9-tetrahydrocannabinol-induced analgesia in mice. Eur. J. Pharmacol. 301:1996;75-81.
25. Richardson J.D., Aanonsen L., Hargreaves K.M. SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol. 319:1997;3-4.
26. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martínez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
27. Romero J., García-Palomero E., Berrendero F., García-Gil L., Hernández M.L., Ramos J.A., Fernández-Ruiz J.J. Atypical location of cannabinoid receptor in white matter areas during rat brain development. Synapse. 26:1997;317-323.
28. 35S]thio]triphosphate binding. PNAS (USA). 92:1995;7242-7246.
29. Sim L.J., Selley D.E., Xiao R., Childers S.R. Differences in G-protein activation by μ- and δ-opioid, and cannabinoid, receptors in rat striatum. Eur. J. Pharmacol. 307:1996;97-105.
30. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16:1996;8057-8066.
31. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16:1996;2684-2692.
32. 9-tetrahydrocannabinol and κ-opioids in mice. J. Pharmacol. Exp. Ther. 268:1994;1381-1387.
33. 9-tetrahydrocannabinol in mice. Eur. J. Pharmacol. 260:1994;5-13.
34. 9-tetrahydrocannabinol in rats. Eur. J. Pharmacol. 70:1981;219-224.
35. Vaysse P.J.J., Gardner E.L., Zukin R.S. Modulation of rat brain opioid receptors by cannabinoids. J. Pharmacol. Exp. Ther. 241:1987;534-539.
36. Vela G., Ruiz-Gayo M., Fuentes J.A. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. Neuropharmacology. 34:1995;665-668.
37. 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res. 680:1995;142-147.
38. 9-tetrahydrocannabinol facilitates morphine self-administration and changes μ-opioid receptor binding in brain regions related to drug reinforcement in adult offspring female rats. Brain Res. (submitted).
39. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine in mice. J. Pharmacol. Exp. Ther. 262:1992;10-18.
40. Welch S.P. Blockade of cannabinoid induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice. J. Pharmacol. Exp. Ther. 265:1993;633-640.
41. Yaksh T.L The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. J. Clin. Pharmacol. 21:1981;334s-340.